Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation

  • Authors:
    • Zhiqiang Qu
    • Fengxiang Zhang
    • Weiwei Chen
    • Tao Lin
    • Yongming Sun
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China, Department of General Surgery, Tongliao City Hospital, Tongliao, Inner Mongolia 028000, P.R. China, Department of Disinfecting Supply Division, Tongliao City Hospital, Tongliao, Inner Mongolia 028000, P.R. China
    Copyright: © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3661-3668
    |
    Published online on: August 3, 2020
       https://doi.org/10.3892/etm.2020.9088
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Transforming growth factor β1 (TGF‑β1) can promote the proliferation and differentiation of intervertebral disc cells and participates in its repair process. However, whether TGF‑β1 engages in the process of disc degeneration has not yet been fully elucidated. The present study aimed to investigate the function of high‑dose TGF‑β1 on the metabolism of nucleus pulposus cells (NPCs). TGF‑β1 levels in human degenerative intervertebral disc tissues and tumor necrosis factor (TNF)‑α‑induced degenerative NPCs were analyzed. Furthermore, NPCs were treated with TGF‑β1 and inhibitors of TGF‑β1 receptors [ALK tyrosine kinase receptor (ALK) 1 and ALK5] to determine the effect of the receptors in the mediation of NPC degeneration. The NPC state was determined by the components of secretory collagen I/II, tissue inhibitor of metalloproteinase‑3 (TIMP‑3) and matrix metalloproteinase (MMP)‑13. The mRNA expression of Smad1/2/3/5/8, the downstream gene of TGF‑β1 mediated by ALK, was also measured. Results showed that TGF‑β1 and ALK1 were positively associated with the degree of degeneration of NP or NPCs in vitro, but negatively associated with ALK5. Furthermore, high‑doses of TGF‑β1 suppressed collagen II, but enhanced collagen I, TIMP‑3, MMP‑13, ALK1/5 and Smad1/2/3/5/8 expression. ALK5 inhibition induced the suppression of Smad2/3 and aggravated high‑dose TGF‑β1‑induced NPC degeneration, as shown by the reduction in collagen II and increase in collagen I, TIMP‑3 and MMP‑13. By contrast, ALK1 inhibition resulted in Smad1/5/8 suppression and alleviated high‑dose TGF‑β1‑induced NPC degeneration. Taken together, it was concluded that high‑doses of TGF‑β1 contributed to the degeneration of NPCs via the upregulation of ALK1 and Smad1/5/8.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Zhao CQ, Wang LM, Jiang LS and Dai LY: The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 6:247–261. 2007.PubMed/NCBI View Article : Google Scholar

2 

Zhou TY, Wu YG, Zhang YZ, Bao YW and Zhao Y: SIRT3 retards intervertebral disc degeneration by anti-oxidative stress by activating the SIRT3/FOXO3/SOD2 signaling pathway. Eur Rev Med Pharmacol Sci. 23:9180–9188. 2019.PubMed/NCBI View Article : Google Scholar

3 

Sampara P, Banala RR, Vemuri SK, Av GR and Gpv S: Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: A review. Gene Ther. 25:67–82. 2018.PubMed/NCBI View Article : Google Scholar

4 

Vo NV, Hartman RA, Patil PR, Risbud MV, Kletsas D, Iatridis JC, Hoyland JA, Le Maitre CL, Sowa GA and Kang JD: Molecular mechanisms of biological aging in intervertebral discs. J Orthop Res. 34:1289–1306. 2016.PubMed/NCBI View Article : Google Scholar

5 

Ashley JW, Enomoto-Iwamoto M, Smith LJ, Mauck RL, Chan D, Lee J, Heyworth MF, An H and Zhang Y: Intervertebral disc development and disease-related genetic polymorphisms. Genes Dis. 3:171–177. 2016.PubMed/NCBI View Article : Google Scholar

6 

Wu M, Chen G and Li YP: TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4(16009)2016.PubMed/NCBI View Article : Google Scholar

7 

Yang Y, He X, Li Y, Feng J, Pang H, Wang J and Liu Q: Association of transforming growth factor-β1 with pathological grading of intervertebral disc degeneration. Nan Fang Yi Ke Da Xue Xue Bao. 32:897–900. 2012.(In Chinese).

8 

Tolonen J, Gronblad M, Vanharanta H, Virri J, Guyer RD, Rytomaa T and Karaharju EO: Growth factor expression in degenerated intervertebral disc tissue. An immunohistochemical analysis of transforming growth factor beta, fibroblast growth factor and platelet-derived growth factor. Eur Spine J. 15:588–596. 2006.PubMed/NCBI View Article : Google Scholar

9 

Tolonen J, Gronblad M, Virri J, Seitsalo S, Rytomaa T and Karaharju E: Transforming growth factor beta receptor induction in herniated intervertebral disc tissue: An immunohistochemical study. Eur Spine J. 10:172–176. 2001.PubMed/NCBI View Article : Google Scholar

10 

Chen S, Liu S, Ma K, Zhao L, Lin H and Shao Z: TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage. 27:1109–1117. 2019.

11 

Uchiyama Y, Guttapalli A, Gajghate S, Mochida J, Shapiro IM and Risbud MV: SMAD3 functions as a transcriptional repressor of acid-sensing ion channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc. J Bone Miner Res. 23:1619–1628. 2008.PubMed/NCBI View Article : Google Scholar

12 

Tian Y, Yuan W, Li J, Wang H, Hunt MG, Liu C, Shapiro IM and Risbud MV: TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: Implications in intervertebral disc degeneration. Matrix Biol. 50:39–52. 2016.PubMed/NCBI View Article : Google Scholar

13 

Colombier P, Clouet J, Boyer C, Ruel M, Bonin G, Lesoeur J, Moreau A, Fellah BH, Weiss P, Lescaudron L, et al: TGF-β1 and GDF5 act synergistically to drive the differentiation of human adipose stromal cells toward nucleus pulposus-like cells. Stem Cells. 34:653–667. 2016.PubMed/NCBI View Article : Google Scholar

14 

Griffith JF, Wang YX, Antonio GE, Choi KC, Yu A, Ahuja AT and Leung PC: Modified Pfirrmann grading system for lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 32:E708–E712. 2007.PubMed/NCBI View Article : Google Scholar

15 

Ten DP, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K and Heldin CH: Characterization of type I receptors for transforming growth factor-beta and activin. Science. 264:101–104. 1994.PubMed/NCBI View Article : Google Scholar

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

17 

Patil P, Niedernhofer LJ, Robbins PD, Lee J, Sowa G and Vo N: Cellular senescence in intervertebral disc aging and degeneration. Curr Mol Biol Rep. 4:180–190. 2018.PubMed/NCBI View Article : Google Scholar

18 

van der Kraan PM, Blaney DE, Blom A and van den Berg WB: TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: Modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage. 17:1539–1545. 2009.PubMed/NCBI View Article : Google Scholar

19 

Wang XH, Hong X, Zhu L, Wang YT, Bao JP, Liu L, Wang F and Wu XT: Tumor necrosis factor alpha promotes the proliferation of human nucleus pulposus cells via nuclear factor-κB, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. Exp Biol Med (Maywood). 240:411–417. 2015.PubMed/NCBI View Article : Google Scholar

20 

Zhu Y, Tao H, Jin C, Liu Y, Lu X, Hu X and Wang X: Transforming growth factor-beta1 induces type II collagen and aggrecan expression via activation of extracellular signal-regulated kinase 1/2 and Smad2/3 signaling pathways. Mol Med Rep. 12:5573–5579. 2015.PubMed/NCBI View Article : Google Scholar

21 

Roberts S, Evans H, Trivedi J and Menage J: Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 88 (Suppl 2):S10–S14. 2006.PubMed/NCBI View Article : Google Scholar

22 

Peck SH, McKee KK, Tobias JW, Malhotra NR, Harfe BD and Smith LJ: Whole Transcriptome analysis of notochord-derived cells during embryonic formation of the nucleus pulposus. Sci Rep. 7(10504)2017.PubMed/NCBI View Article : Google Scholar

23 

Jin H, Shen J, Wang B, Wang M, Shu B and Chen D: TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue. FEBS Lett. 585:1209–1215. 2011.PubMed/NCBI View Article : Google Scholar

24 

Yang H, Gao F, Li X, Wang J, Liu H and Zheng Z: TGF-β1 antagonizes TNF-α induced up-regulation of matrix metalloproteinase 3 in nucleus pulposus cells: Role of the ERK1/2 pathway. Connect Tissue Res. 56:461–468. 2015.PubMed/NCBI View Article : Google Scholar

25 

Yang H, Cao C, Wu C, Yuan C, Gu Q, Shi Q and Zou J: TGF-β1 suppresses inflammation in cell therapy for intervertebral disc degeneration. Sci Rep. 5(13254)2015.PubMed/NCBI View Article : Google Scholar

26 

Singh K, Masuda K, Thonar EJ, An HS and Cs-Szabo G: Age-related changes in the extracellular matrix of nucleus pulposus and anulus fibrosus of human intervertebral disc. Spine (Phila Pa 1976). 34:10–16. 2009.PubMed/NCBI View Article : Google Scholar

27 

Mehra A and Wrana JL: TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol. 80:605–622. 2002.PubMed/NCBI View Article : Google Scholar

28 

Kwon YJ, Lee JW, Moon EJ, Chung YG, Kim OS and Kim HJ: Anabolic effects of Peniel. 2000, a peptide that regulates TGF-beta1 signaling on intervertebral disc degeneration. Spine (Phila Pa 1976). 38:E49–E58. 2013.PubMed/NCBI View Article : Google Scholar

29 

Hu B, Xu C, Cao P, Tian Y, Zhang Y, Shi C, Xu J, Yuan W and Chen H: TGF-β stimulates expression of chondroitin polymerizing factor in nucleus pulposus cells through the Smad3, RhoA/ROCK1, and MAPK signaling pathways. J Cell Biochem. 119:566–579. 2018.PubMed/NCBI View Article : Google Scholar

30 

Chen MH, Sun JS, Liao SY, Tai PA, Li TC and Chen MH: Low-intensity pulsed ultrasound stimulates matrix metabolism of human annulus fibrosus cells mediated by transforming growth factor β1 and extracellular signal-regulated kinase pathway. Connect Tissue Res. 56:219–227. 2015.PubMed/NCBI View Article : Google Scholar

31 

Wang X, Zhu Y, Tao H, Jin C, Liu Y, Lu X, Hu X and Fan C: Interaction of ERK1/2 and Smad2/3 signaling pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytes. Arch Biochem Biophys. 564:229–236. 2014.PubMed/NCBI View Article : Google Scholar

32 

Van Caam A, Madej W, Garcia DVA, Goumans MJ, Ten DP, Blaney DE and van der Kraan P: TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity. Arthritis Res Ther. 19(112)2017.PubMed/NCBI View Article : Google Scholar

33 

Derynck R and Budi EH: Specificity, versatility, and control of TGF-β family signaling. Sci Signal. 12(eaav5183)2019.PubMed/NCBI View Article : Google Scholar

34 

Mariani E, Pulsatelli L and Facchini A: Signaling pathways in cartilage repair. Int J Mol Sci. 15:8667–8698. 2014.PubMed/NCBI View Article : Google Scholar

35 

Brenner DA, Rippe RA, Rhodes K, Trotter JF and Breindl M: Fibrogenesis and type I collagen gene regulation. J Lab Clin Med. 124:755–760. 1994.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qu Z, Zhang F, Chen W, Lin T and Sun Y: High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation. Exp Ther Med 20: 3661-3668, 2020.
APA
Qu, Z., Zhang, F., Chen, W., Lin, T., & Sun, Y. (2020). High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation. Experimental and Therapeutic Medicine, 20, 3661-3668. https://doi.org/10.3892/etm.2020.9088
MLA
Qu, Z., Zhang, F., Chen, W., Lin, T., Sun, Y."High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation". Experimental and Therapeutic Medicine 20.4 (2020): 3661-3668.
Chicago
Qu, Z., Zhang, F., Chen, W., Lin, T., Sun, Y."High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3661-3668. https://doi.org/10.3892/etm.2020.9088
Copy and paste a formatted citation
x
Spandidos Publications style
Qu Z, Zhang F, Chen W, Lin T and Sun Y: High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation. Exp Ther Med 20: 3661-3668, 2020.
APA
Qu, Z., Zhang, F., Chen, W., Lin, T., & Sun, Y. (2020). High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation. Experimental and Therapeutic Medicine, 20, 3661-3668. https://doi.org/10.3892/etm.2020.9088
MLA
Qu, Z., Zhang, F., Chen, W., Lin, T., Sun, Y."High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation". Experimental and Therapeutic Medicine 20.4 (2020): 3661-3668.
Chicago
Qu, Z., Zhang, F., Chen, W., Lin, T., Sun, Y."High‑dose TGF‑β1 degrades human nucleus pulposus cells via ALK1‑Smad1/5/8 activation". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3661-3668. https://doi.org/10.3892/etm.2020.9088
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team